Code Rebel Cp Cmn (CDRB) 2.16 $CDRB 3-DAY DEADLINE

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Code Rebel Cp Cmn (CDRB) 2.16 $CDRB

3-DAY DEADLINE ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Code Rebel Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 08, 3:34PM CDT
IRVINE, CA / ACCESSWIRE / July 8, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Code Rebel Corporation ("Code Rebel" or the "Company" (Nasdaq: CDRB). Investors who purchased or otherwise acquired shares between August 17, 2015 and May 5, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016 lead plaintiff motion deadline.
CDRB: 2.16 (-0.51)

July 11 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Code Rebel Corp
BusinessWire - Fri Jul 08, 1:40PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Code Rebel Corp ("Code Rebel" or the "Company" (NASDAQ: CDRB; OTC: CDRBQ) securities between August 17, 2015 and May 5, 2016, inclusive (the "Class Period". Code Rebel investors have until July 11, 2016 to file a lead plaintiff motion.
CDRB: 2.16 (-0.51)

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Code Rebel Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jul 07, 10:40AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Code Rebel Corporation ("Code Rebel" or the "Company" (Nasdaq: CDRB) concerning possible violations of federal securities laws between August 17, 2015 and May 5, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
CDRB: 2.16 (-0.51)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Code Rebel Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - CDRB
GlobeNewswire - Wed Jul 06, 9:42AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
CDRB: 2.16 (-0.51)

JULY 11 DEADLINE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Code Rebel Corporation And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Mon Jun 20, 7:40PM CDT
IRVINE, CA / ACCESSWIRE / June 20, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Code Rebel Corporation ("Code Rebel" or the "Company" (Nasdaq: CDRB). Investors who purchased or otherwise acquired shares between August 17, 2015 and May 5, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016, lead plaintiff motion deadline.
CDRB: 2.16 (-0.51)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Code Rebel Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - CDRB
BusinessWire - Wed Jun 15, 8:49AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
CDRB: 2.16 (-0.51)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Code Rebel Corporation and a Lead Plaintiff Deadline of July 11, 2016
BusinessWire - Fri Jun 10, 1:03PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Code Rebel Corporation (NASDAQ:CDRB) securities between August 17, 2015 through May 5, 2016.
CDRB: 2.16 (-0.51)

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Code Rebel Corporation - CDRB
GlobeNewswire - Fri Jun 10, 12:11PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Code Rebel Corporation securities (NASDAQ:CDRB) from August 17, 2015 through May 5, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Code Rebel investors under the federal securities laws.
CDRB: 2.16 (-0.51)

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Code Rebel Corporation and Reminds Investors With Losses to Contact the Firm
BusinessWire - Thu Jun 09, 1:02PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Code Rebel Corporation ("Code Rebel" or the "Company" (Nasdaq: CDRB). Investors who purchased or otherwise acquired shares between August 17, 2015 and May 5, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the June 11, 2016, lead plaintiff motion deadline.
CDRB: 2.16 (-0.51)

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Code Rebel Corp Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 09, 9:30AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Code Rebel Corp ("Code Rebel" or the "Company" (NASDAQ: CDRB) securities between August 17, 2015 and May 5, 2016, inclusive (the "Class Period". Code Rebel investors have until July 11, 2016 to file a lead plaintiff motion.
CDRB: 2.16 (-0.51)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Code Rebel Corporation and a Lead Plaintiff Deadline of July 11, 2016 -- CDRB
GlobeNewswire - Mon Jun 06, 2:11PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Code Rebel Corporation (NASDAQ:CDRB) securities between August 17, 2015 through May 5, 2016.
CDRB: 2.16 (-0.51)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Code Rebel Corporation to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- CDRB
GlobeNewswire - Thu Jun 02, 8:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Code Rebel Corporation (Nasdaq:CDRB) ("Code Rebel" or the "Company" securities during the period between August 17, 2015 and May 5, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 11, 2016 to seek appointment as lead plaintiff.
CDRB: 2.16 (-0.51)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Code Rebel Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - CDRB
GlobeNewswire - Fri May 27, 11:27AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
CDRB: 2.16 (-0.51)

Lifshitz & Miller Law Firm Announces Investigation of Code Rebel Corporation, Domino's Pizza, Inc., Energy Recovery, Inc., Intercloud Systems, Inc., Inventure Foods, Inc., Liquidity Services, Inc., NewLink Genetics Corporation, and Ocwen Financial Corp.
PR Newswire - Tue May 24, 2:17PM CDT
Code Rebel Corporation (CDRB)
CDRB: 2.16 (-0.51), OCN: 2.03 (+0.01), NLNK: 10.86 (+0.22), LQDT: 8.32 (+0.19), SNAK: 8.85 (unch), DPZ: 145.86 (+0.41), ICLD: 0.47 (-0.03), ERII: 10.40 (-0.09)

Glancy Prongay & Murray Commences Investigation on Behalf of Code Rebel Corp Investors
BusinessWire - Tue May 24, 12:39PM CDT
Glancy Prongay & Murray LLP ("GPM" announces an investigation on behalf of investors of Code Rebel Corp ("Code Rebel" or the "Company" (NASDAQ: CDRB) concerning the Company and its officers' possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors.
CDRB: 2.16 (-0.51)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Code Rebel Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - CDRB
ACCESSWIRE - Mon May 23, 3:00PM CDT
NEW YORK, NY / ACCESSWIRE / May 23, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
CDRB: 2.16 (-0.51)

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Code Rebel Corporation to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit
BusinessWire - Fri May 20, 10:30PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Code Rebel Corporation (Nasdaq: CDRB) ("Code Rebel" or the "Company" securities during the period between August 17, 2015 and May 5, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 11, 2016 to seek appointment as lead plaintiff.
CDRB: 2.16 (-0.51)

Nasdaq Changes Trade Halt Status of Code Rebel Corp.
GlobeNewswire - Thu May 19, 3:45PM CDT
The Nasdaq Stock Market (Nasdaq:NDAQ) announced today that the trading halt status in Code Rebel Corp. (Nasdaq:CDRB) was changed to "additional information requested" from the company. Trading in the company's stock had been halted for an SEC suspension on May 6, 2016 at a last price of $2.16.
CDRB: 2.16 (-0.51), NDAQ: 71.50 (+0.30)

IMPORTANT CODE REBEL SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been commenced on behalf of shareholders of Code Rebel Corporation -- CDRB
GlobeNewswire - Wed May 18, 6:30PM CDT
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Code Rebel Corporation ("Code Rebel" or the "Company" (Nasdaq:CDRB) in the United States District Court for the Southern District of New York on behalf of purchasers of Code Rebel common stock between August 17, 2015 and May 5, 2016, inclusive (the "Class Period".
CDRB: 2.16 (-0.51)

Aegis Identity Software Announces Termination of Proposed Merger with Code Rebel Corporation
PR Newswire - Wed May 18, 4:00AM CDT
Aegis Identity Software, Inc., a leading education technology (Ed-Tech) provider of Identity and Access Management solutions for the education marketplace ("Aegis Identity", announced today that it has terminated the definitive merger agreement that it had entered into with Code Rebel Corporation on March 11, 2016, and the merger contemplated thereby, effective immediately.
CDRB: 2.16 (-0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading